Page last updated: 2024-11-04

sulfanilamide and Conjunctivitis, Inclusion

sulfanilamide has been researched along with Conjunctivitis, Inclusion in 2 studies

Conjunctivitis, Inclusion: An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ORMSBY, HL1
THOMPSON, GA1
COUSINEAU, GG1
LLOYD, LA1
HASSARD, J1
NIEDERMEIER, S1

Other Studies

2 other studies available for sulfanilamide and Conjunctivitis, Inclusion

ArticleYear
Topical therapy in inclusion conjunctivitis.
    American journal of ophthalmology, 1952, Volume: 35, Issue:12

    Topics: Chlortetracycline; Conjunctivitis; Conjunctivitis, Inclusion; Cortisone; Humans; Oxytetracycline; Su

1952
[On the treatment of epidemic keratoconjunctivitis with Prednisulmide].
    Klinische Monatsblatter fur Augenheilkunde und fur augenarztliche Fortbildung, 1962, Volume: 141

    Topics: Conjunctivitis, Inclusion; Conjunctivitis, Viral; Humans; Keratoconjunctivitis; Prednisolone; Sulfan

1962